News Sentiment

GILD sentiment intelligence

Gilead Sciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 54 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 129.83 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

-1.1% over one week, +4.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

GILD (NASDAQ: GILD) holder plans 3,000-share common stock sale

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -1.1% Price digesting
Trend fit Trend inactive 4.1% over four weeks
Fair value 36.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 26
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 4
TIKR.com 4
The Globe and Mail 3
simplywall.st 3
Simply Wall St. 3
Stock Titan 2
MarketWatch 2

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 4
Deals and strategy 3
Analyst action 3
Regulatory and legal 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-52 of 52